These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 22000773

  • 1. Evaluation of intracoronary adenosine to prevent periprocedural myonecrosis in elective percutaneous coronary intervention (from the PREVENT-ICARUS Trial).
    De Luca G, Iorio S, Venegoni L, Marino P.
    Am J Cardiol; 2012 Jan 15; 109(2):202-7. PubMed ID: 22000773
    [Abstract] [Full Text] [Related]

  • 2. New method of intracoronary adenosine injection to prevent microvascular reperfusion injury in patients with acute myocardial infarction undergoing percutaneous coronary intervention.
    Grygier M, Araszkiewicz A, Lesiak M, Janus M, Kowal J, Skorupski W, Pyda M, Mitkowski P, Grajek S.
    Am J Cardiol; 2011 Apr 15; 107(8):1131-5. PubMed ID: 21310372
    [Abstract] [Full Text] [Related]

  • 3. Effect of adenosine intracoronary bolus on myonecrosis occurrence in elective PCI (RACE trial).
    Sardella G, Lucisano L, Mancone M, Canali E, De Carlo C, Stio RE, Calcagno S, Brasolin B, Fedele F.
    Int J Cardiol; 2012 Mar 22; 155(3):456-9. PubMed ID: 22240750
    [No Abstract] [Full Text] [Related]

  • 4. Impact of Intracoronary Adenosine on Myonecrosis in Patients with Unstable Angina Pectoris Undergoing Percutaneous Coronary Intervention.
    Kizilirmak F, Gunes HM, Demir GG, Gokdeniz T, Guler E, Cakal B, Omaygenç MO, Yılmaz F, Savur U, Barutcu I.
    Cardiovasc Drugs Ther; 2015 Dec 22; 29(6):519-526. PubMed ID: 26631392
    [Abstract] [Full Text] [Related]

  • 5. Rosuvastatin pretreatment in patients undergoing elective PCI to reduce the incidence of myocardial periprocedural necrosis: the ROMA trial.
    Sardella G, Conti G, Donahue M, Mancone M, Canali E, De Carlo C, Di Roma A, Calcagno S, Lucisano L, Fedele F.
    Catheter Cardiovasc Interv; 2013 Jan 01; 81(1):E36-43. PubMed ID: 22517610
    [Abstract] [Full Text] [Related]

  • 6. Effect of high-dose intracoronary adenosine administration during primary percutaneous coronary intervention in acute myocardial infarction: a randomized controlled trial.
    Fokkema ML, Vlaar PJ, Vogelzang M, Gu YL, Kampinga MA, de Smet BJ, Jessurun GA, Anthonio RL, van den Heuvel AF, Tan ES, Zijlstra F.
    Circ Cardiovasc Interv; 2009 Aug 01; 2(4):323-9. PubMed ID: 20031735
    [Abstract] [Full Text] [Related]

  • 7. Safety and efficacy of intracoronary adenosine administration in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: a meta-analysis of randomized controlled trials.
    Singh M, Shah T, Khosla K, Singh P, Molnar J, Khosla S, Arora R.
    Ther Adv Cardiovasc Dis; 2012 Jun 01; 6(3):101-14. PubMed ID: 22562999
    [Abstract] [Full Text] [Related]

  • 8. Intracoronary ST-segment shift soon after elective percutaneous coronary intervention accurately predicts periprocedural myocardial injury.
    Balian V, Galli M, Marcassa C, Cecchin G, Child M, Barlocco F, Petrucci E, Filippini G, Michi R, Onofri M.
    Circulation; 2006 Oct 31; 114(18):1948-54. PubMed ID: 17060382
    [Abstract] [Full Text] [Related]

  • 9. Periprocedural use of tirofiban in elective percutaneous coronary intervention for long coronary lesions in stable patients with overlapping drug-eluting stents--the PETITION study: a prospective, randomized, multicenter study.
    Zhang Q, Wang XL, Liao ML, Hu J, Yang ZK, Ding FH, Zhang JS, Du R, Zhu TQ, Shen WF, Zhang RY.
    Catheter Cardiovasc Interv; 2015 Mar 31; 85 Suppl 1():762-9. PubMed ID: 25630513
    [Abstract] [Full Text] [Related]

  • 10. Randomized evaluation of intracoronary nitroprusside vs. adenosine after thrombus aspiration during primary percutaneous coronary intervention for the prevention of no-reflow in acute myocardial infarction: the REOPEN-AMI study protocol.
    Niccoli G, D'amario D, Spaziani C, Cosentino N, Marino M, Rigattieri S, Schiavo PL, De Vita MR, Tarantino F, Bartorelli A, Fabbiocchi F, Prati F, Imola F, Valgimigli M, Ferrari R, Crea F.
    J Cardiovasc Med (Hagerstown); 2009 Jul 31; 10(7):585-92. PubMed ID: 19384242
    [Abstract] [Full Text] [Related]

  • 11. Open-label, randomized, placebo-controlled evaluation of intracoronary adenosine or nitroprusside after thrombus aspiration during primary percutaneous coronary intervention for the prevention of microvascular obstruction in acute myocardial infarction: the REOPEN-AMI study (Intracoronary Nitroprusside Versus Adenosine in Acute Myocardial Infarction).
    Niccoli G, Rigattieri S, De Vita MR, Valgimigli M, Corvo P, Fabbiocchi F, Romagnoli E, De Caterina AR, La Torre G, Lo Schiavo P, Tarantino F, Ferrari R, Tomai F, Olivares P, Cosentino N, D'Amario D, Leone AM, Porto I, Burzotta F, Trani C, Crea F.
    JACC Cardiovasc Interv; 2013 Jun 31; 6(6):580-9. PubMed ID: 23683738
    [Abstract] [Full Text] [Related]

  • 12. Comparison of high reloading ROsuvastatin and Atorvastatin pretreatment in patients undergoing elective PCI to reduce the incidence of MyocArdial periprocedural necrosis. The ROMA II trial.
    Sardella G, Lucisano L, Mancone M, Conti G, Calcagno S, Stio RE, Pennacchi M, Biondi-Zoccai G, Canali E, Fedele F.
    Int J Cardiol; 2013 Oct 09; 168(4):3715-20. PubMed ID: 23849964
    [Abstract] [Full Text] [Related]

  • 13. Effects of liposomal prostaglandin E1 on periprocedural myocardial injury in patients with unstable angina undergoing an elective percutaneous coronary intervention.
    Fan Y, Jiang Y, Fu X, Cai J, Wang Y, Li W, Gu X, Xing K, Bai S, Bi X.
    Coron Artery Dis; 2015 Dec 09; 26(8):671-7. PubMed ID: 26267747
    [Abstract] [Full Text] [Related]

  • 14. The effect of intravenous vitamin C infusion on periprocedural myocardial injury for patients undergoing elective percutaneous coronary intervention.
    Wang ZJ, Hu WK, Liu YY, Shi DM, Cheng WJ, Guo YH, Yang Q, Zhao YX, Zhou YJ.
    Can J Cardiol; 2014 Jan 09; 30(1):96-101. PubMed ID: 24365194
    [Abstract] [Full Text] [Related]

  • 15. Effect of new method of intracoronary adenosine injection during primary percutaneous coronary intervention on microvascular reperfusion injury - clinical outcome and 1-year follow-up.
    Grygier M, Araszkiewicz A, Lesiak M, Grajek S.
    Cardiology; 2013 Jan 09; 124(3):199-206. PubMed ID: 23548697
    [Abstract] [Full Text] [Related]

  • 16. Effect of intracoronary anisodamine and diltiazem administration during primary percutaneous coronary intervention in acute myocardial infarction.
    Peng Y, Fu X, Li W, Geng W, Xing K, Ru L, Sun J, Zhao Y.
    Coron Artery Dis; 2014 Dec 09; 25(8):645-52. PubMed ID: 25230304
    [Abstract] [Full Text] [Related]

  • 17. Intracoronary injection of adenosine before reperfusion in patients with ST-segment elevation myocardial infarction: a randomized controlled clinical trial.
    Garcia-Dorado D, García-del-Blanco B, Otaegui I, Rodríguez-Palomares J, Pineda V, Gimeno F, Ruiz-Salmerón R, Elizaga J, Evangelista A, Fernandez-Avilés F, San-Román A, Ferreira-González I.
    Int J Cardiol; 2014 Dec 20; 177(3):935-41. PubMed ID: 25449504
    [Abstract] [Full Text] [Related]

  • 18. Intracoronary compared with intravenous bolus abciximab application in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: the randomized Leipzig immediate percutaneous coronary intervention abciximab IV versus IC in ST-elevation myocardial infarction trial.
    Thiele H, Schindler K, Friedenberger J, Eitel I, Fürnau G, Grebe E, Erbs S, Linke A, Möbius-Winkler S, Kivelitz D, Schuler G.
    Circulation; 2008 Jul 01; 118(1):49-57. PubMed ID: 18559698
    [Abstract] [Full Text] [Related]

  • 19. A pilot randomized study of ranolazine for reduction of myocardial damage during elective percutaneous coronary intervention.
    Pelliccia F, Pasceri V, Marazzi G, Rosano G, Greco C, Gaudio C.
    Am Heart J; 2012 Jun 01; 163(6):1019-23. PubMed ID: 22709755
    [Abstract] [Full Text] [Related]

  • 20. The role of Glucagon-Like Peptide 1 Loading on periprocedural myocardial infarction During elective PCI (GOLD-PCI study): A randomized, placebo-controlled trial.
    Giblett JP, Clarke S, Zhao T, McCormick LM, Braganza DM, Densem CG, O'Sullivan M, Adlam D, Clarke SC, Steele J, Fielding S, West NEJ, Villar SS, Hoole SP.
    Am Heart J; 2019 Sep 01; 215():41-51. PubMed ID: 31277053
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.